Diabetic Macular Edema (DME)

Diabetic Macular Edema (DME) is the indication for 5 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as: Diabetic Macular Edema · Diabetic Macular Oedema · Macular Edema, Diabetic · Diabetic Macula Edema · Diabetic Macular Edema(DME)
Classified under: Disorders of Glucose Metabolism
Eye Disease
Infections
Pancreatic Diseases
Indicated drugs: Aflibercept
Dexamethasone
Faricimab
Fluocinolone acetonide
Ranibizumab

Resolves to

Vocabularies

SNOMED CT312912001MedDRA10012688UMLSC0730285

What you can answer from here — as of October 22, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

455Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Diabetic Macular Edema (DME) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.